Form 4: Hologic Executive Reports Routine Tax-Related Stock Disposition

Hologic Inc. (HOLX) Division President, Brandon Schnittker, reported the disposition of 69 shares of common stock, valued at $62.17 per share, to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Brandon Schnittker, Division President, GYN Surgical at Hologic Inc. (HOLX), filed a Form 4 reporting a transaction on May 30, 2025.
• The transaction involved the disposition of 69 shares of Hologic common stock at a price of $62.17 per share.
• These shares were withheld by the company to satisfy tax obligations incurred upon the settlement of restricted stock units (RSUs) for which service-based vesting requirements had been met.
• Following this transaction, Mr. Schnittker beneficially owns 6,094 shares of Hologic common stock directly.

Sentiment

Score: 5

Explanation: The transaction reported is a routine tax-related disposition of shares following RSU vesting, which is a neutral event from an investment sentiment perspective. It does not indicate any positive or negative operational or financial performance.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs) for Mr. Schnittker, signifying the fulfillment of service-based requirements and a component of executive compensation.

Negatives

• No negative implications are directly associated with this routine tax-related stock disposition.

Risks

• The document does not disclose any specific risks related to the company's operations or financial health.

Future Outlook

The Form 4 filing is a report of a past insider transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reflects a common practice in executive compensation where a portion of vested equity awards, such as Restricted Stock Units (RSUs), is withheld by the company to cover the executive's tax liabilities. This is a standard mechanism across various industries for managing equity compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a small, routine tax-related disposition by an executive, not indicative of a change in investment thesis or company performance.
• Employees: No direct impact on the broader employee base, as this relates to executive compensation.

Next Steps

• The document does not outline any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

Hologic, HOLX, Form 4, Insider Transaction, Stock Disposition, Restricted Stock Units, RSU Vesting, Tax Withholding, Executive Compensation, Brandon Schnittker